Guggenheim analyst Yatin Suneja downgraded Tourmaline Bio (NASDAQ: TRML) from Buy to Neutral.The analyst comments "We are updating our PT ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE